Recent Quotes (30 days)

You have no recent quotes
chg | %

Life Science Developments Ltd news

   Watch this stock
Showing stories 1 - 10 of about 71   

Articles published

LIFE 3.06 -0.19 (-6.00%)
price chart
Could Life Science Developments Ltd Crash Even More? The Stock Just Had a Gap Down
The stock of Life Science Developments Ltd (LON:LIFE) gapped down by GBX 0.005 today and has GBX 2.92 target or 13.00% below today's GBX 3.36 share price.
Aberdeen firm honoured at Life Sciences Awards
Aberdeen firm NovaBiotics won the award for investment of the year at the Scottish Enterprise (SE) Life Sciences Awards in Edinburgh last night.
Plans for �60m leisure, health and science complex in Llanelli gather pace
The hope is that private and European funding will be secured and that the Delta Lakes development would become the West Wales hub of Swansea University's Institute of Life Science, which has already created hundreds of jobs. It is still early days and ...
Life Sciences Bridging Fund offers antibiotic 'lifeline'
The Life Sciences Bridging Fund, which has been operating for almost a year, has been aimed at getting the best Welsh research through that vital stage.
J&J and GSK join Medicxi's European life sciences push
Johnson & Johnson and GlaxoSmithKline have teamed up behind a €210m venture capital fund to invest in European life sciences amid growing momentum in the region's biotech sector. The rival pharmaceuticals groups will each contribute more than €50m ...
Medicxi Ventures comprises al l of the existing life sciences team ...  PharmiWeb.com (press release)
Patients with long-term conditions need a joined-up NHS
The programme is focused on long-term conditions and mental health, and is a collaboration between the NHS and some big private sector names including Verily (formerly Google Life Sciences), IBM and Philips. The idea is to ... These are all good ideas ...
UK in a life sciences 'renaissance' as funding booms
“If you look at some of the landmark deals we have done, it is clear London is establishing itself as a global hub for life science,” he said. The pace of innovation in London and the South East, coupled with the fertile funding environment, meant the ...
Market forces will put low-carbon technologies in the hands of the consumer
A successful businessman and former government Chief Scientific Advisor, Sir David gave his reflections on the UN Climate Change Conference in Paris (COP21) at a panel discussion organised by the Grantham Institute at Imperial College London on 2 ...
Monsanto and BASF may reap more from partnership after Syngenta sale
VX SYNN.VX ). A growing world population, limited farm land, higher meat consumption and biofuel use are driving demand for anything that improves agricultural productivity and BASF is also keen to expand in the normally high-margin growth market ...
Life Sciences Minister George Freeman MP – Leading the way for personalised ...
Larushka Mellor, Head of Public Affairs and Policy at Merck asked the Life Sciences Minister, George Freeman MP for his thoughts on future of Personalised Medicine in the UK.